Abvc Biopharma Inc (ABVC) Return on Investment ROI from the first quarter of 2026 to first quarter of 2024 and for the year 2026, average high and low, overall ranking from Mar 31 2026 to Sep 30 2024 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Abvc Biopharma Inc   (NASDAQ: ABVC)


Abvc Biopharma Inc's ROI from its first quarter of 2026 to the first quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Abvc Biopharma Inc's ROI in the first quarter of 2026?
Abvc Biopharma Inc recorded a cumulative net loss of $-7 million during 12 months ending in the first quarter of 2026, resulting in a negative return on investment (ROI) of -45.18%.

Within the Healthcare sector 412 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2025 from 0 to 3152.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2026)
I. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Sep 30 2024)
III. Quarter
Y / Y Investment Change TTM 342.86 % 296.94 % 123.38 % 12.5 % -42.15 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 16 17 17 12 11
Return On Investment (TTM) -45.18 % -38.86 % -45.96 % -84.7 % -218.58 %
ABVC's Overall Ranking # 3152 # 0 # 1052 # 3041 # 3453
Seq. Investment Change TTM 10.37 % 38.75 % 63.53 % 76.85 % -1.07 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -7 -5 -5 -5 -8

ABVC Company Profile >> Back to ABVC Roi Comparisons >> See Annual ABVC Return On Investment



Return On Investment ABVC's Ranking
Within: No.
Industry # 161
Sector # 413
Overall # 3152

Return On Investment Statistics
High Average Low
-32.93 %
-165.29 %
-536.97 %
(Dec 31 2025)   (Sep 30 2021)







Financial Statements
Abvc Biopharma Inc's I. Quarter Investments $ 16 Millions ABVC's Balance sheet
Abvc Biopharma Inc's I. Quarter Income $ -2 Millions Quarterly ABVC's Income Statement
ABVC's Income by Division See ABVC's Income by Division


ABVC Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017
Total Investments in Millions 15 3 9 -5 2
Y / Y Investment Growth 357.85 % -62.04 % - - 1945.81 %
Net Income in Millions -8 -16 -12 -4 -4
Y / Y Net Income Growth - - - - -
Annual Return On Investment -54.1 % -482.37 % -135.12 % - -164.7 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ABVC's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ABVC's Competitors
Subscribers only: Roi for Abvc Biopharma Inc's Suppliers
Subscribers only: Return On Investment for ABVC's Customers

Other Ratios
ABVC's Roa ABVC's Inventory Turnover Ratio ABVC's Growth Rates ABVC's Dividend Statistics
ABVC's Profitability Ratios ABVC's Asset Turnover Ratio ABVC's Dividend Growth
ABVC's Roe ABVC's Valuation Ratios ABVC's Financial Strength Ratios ABVC's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2026, within Healthcare Sector ROI

Date modified: 2026-09-12T06:12:02+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.